Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 12Lymphoma, Large B-Cell, Diffuse 12Sarcoma, Ewing 4Lymphoma, B-Cell 4Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Neurofibrosarcoma 3Lymphoma, Non-Hodgkin 3Liposarcoma 3Hodgkin Disease 3Fibrosarcoma 3Sarcoma, Synovial 2Sarcoma, Clear Cell 2Rhabdomyosarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Nerve Sheath Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Lymphoma, Follicular 2Lymphoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Histiocytoma, Angiomatoid Fibrous 2Hemangiosarcoma 2Granuloma, Plasma Cell 2Desmoplastic Small Round Cell Tumor 2Dermatofibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Burkitt Lymphoma 2

Interventions

X-Rays 9Specimen Handling 8Phantoms, Imaging 8Magnetic Resonance Spectroscopy 8Vincristine 5Nuclear Medicine Department, Hospital 5Biopsy 5Doxorubicin 4Etoposide 3Dactinomycin 3Cyclophosphamide 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2fludarabine 2erdafitinib 2ensartinib 2cabozantinib 2Temozolomide 2Radiotherapy, Conformal 2Radiotherapy 2Radiation 2LY3023414 2Irinotecan 2talazoparib 1selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × Ifosfamide × 1 year × Clear all
NCT04322318 2026-05-05

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Children's Oncology Group

Phase 2 Recruiting
256 enrolled
Genitourinary

Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡